Birdwatch Note
2022-07-21 16:41:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This is intentionally misleading; ivermectin is on the essential medication list but NOT for the treatment of COVID; it treats parasites https://list.essentialmeds.org/medicines/58 WHO advises AGAINST using ivermectin to treat COVID, many trials have shown it to be ineffective against COVID https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.nejm.org/doi/full/10.1056/NEJMoa2115869
Written by 959EC06571C468B69390728D9BA8D327
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1549866639612690432
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1550159067066294273
- noteId - 1550159067066294273
- participantId - 959EC06571C468B69390728D9BA8D327
- noteAuthorParticipantId -
- createdAtMillis - 1658421696808
- tweetId - 1549866639612690432
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - CHALLENGING
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This is intentionally misleading; ivermectin is on the essential medication list but NOT for the treatment of COVID; it treats parasites https://list.essentialmeds.org/medicines/58 WHO advises AGAINST using ivermectin to treat COVID, many trials have shown it to be ineffective against COVID https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.nejm.org/doi/full/10.1056/NEJMoa2115869
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-07-21 16:41:36 UTC (1658421696808) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
6846F8C32EEB8B1F63A6BED026EA3EA233A093F17FDE19C7E38317C5E32372BE | ||
2022-07-21 16:41:36 UTC (1658421696808) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
959EC06571C468B69390728D9BA8D327 |
Note Ratings
rated at | rated by | |
2022-07-22 09:28:42 -0500 | 0838B7F05D99BBF1F3ECACC60B932970 | Rating Details |
2022-07-21 14:11:54 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
2022-07-25 10:24:05 -0500 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
2022-07-21 15:51:23 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
2022-07-21 18:27:16 -0500 | 0F2A82A6E92750E02A29580118154A7F5248E215D434604DC8031FF3460F3C61 | Rating Details |
2022-07-25 10:57:18 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
2022-07-21 19:55:40 -0500 | 306C001FB157171615E1F826F2B1DC71 | Rating Details |
2022-07-21 15:54:46 -0500 | 3739489EAD581077B0453CE8EF98F44F | Rating Details |
2022-07-22 10:32:01 -0500 | 3BB7EED2CB99A8EE427F20A7FD78B04041086024A0230B85F70D2E8C19D47363 | Rating Details |
2022-07-21 15:56:09 -0500 | 402B540523477342514CCBFB8666A02B089D96DD1F4F411E97879DB801B9D532 | Rating Details |
2022-07-22 11:27:10 -0500 | 4095A5A8EAA510B5FAC80896EAA3CFDDCD709EAD5D3CD1BF30772FB6F2338709 | Rating Details |
2022-07-21 15:56:09 -0500 | 582942164972653872F745BDA14A7E2C | Rating Details |
2022-07-21 18:27:16 -0500 | 758F091176999ACE1FB80B7F5F8B9B13 | Rating Details |
2022-07-21 17:35:01 -0500 | 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC | Rating Details |
2022-07-21 19:55:40 -0500 | 7ACFC241269ACF463C8AFEC7B840E5BE0F5AD92BBFA3C42757299F9311499390 | Rating Details |
2022-07-22 10:32:01 -0500 | 7B0E4EAA4921BB4E48EF4B73D5200CB5 | Rating Details |
2022-07-21 17:35:01 -0500 | 84656258148090979F23255CE507BE9C | Rating Details |
2022-07-21 15:45:14 -0500 | 87F9A3AD36213601F705EC926F742E9B | Rating Details |
2022-07-22 09:28:42 -0500 | 9DB61B6404AAF0A3724FC0FFCAB92BD2DE01C1E4F0FAA6D32FD374B1FDD74CEE | Rating Details |
2022-07-25 10:57:18 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
2022-07-21 15:51:23 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2022-07-21 14:11:54 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-07-21 15:45:14 -0500 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
2022-07-21 13:45:42 -0500 | CEE3A871420F79736E88569AB91963C2 | Rating Details |
2022-07-25 10:24:05 -0500 | DA4507E4409ABAABB16D1F142ADEA36B | Rating Details |
2022-07-22 11:27:10 -0500 | E79F80D13AB1F1B521F313385FFEC814 | Rating Details |
2022-07-21 13:45:42 -0500 | E869CB2545D16F80E5773496CEA2319FF0243270B87C39610F3D5BD892C67EE0 | Rating Details |
2022-07-21 15:54:46 -0500 | F0578459616A456DE79FE43C61B42EECE2C6A1F1021F7E2BE7F846C7005138A4 | Rating Details |
2022-07-25 10:24:05 -0500 | Rating Details | |
2022-07-21 15:56:09 -0500 | Rating Details | |
2022-07-21 19:55:40 -0500 | Rating Details | |
2022-07-22 11:27:10 -0500 | Rating Details | |
2022-07-21 13:45:42 -0500 | Rating Details | |
2022-07-22 09:28:42 -0500 | Rating Details | |
2022-07-22 10:32:01 -0500 | Rating Details | |
2022-07-25 10:57:18 -0500 | Rating Details | |
2022-07-21 14:11:54 -0500 | Rating Details | |
2022-07-21 15:45:14 -0500 | Rating Details | |
2022-07-21 15:51:23 -0500 | Rating Details | |
2022-07-21 18:27:16 -0500 | Rating Details | |
2022-07-21 15:54:46 -0500 | Rating Details | |
2022-07-21 17:35:01 -0500 | Rating Details | |
2023-08-25 12:41:47 -0500 | Rating Details |